Advertisementspot_img
Thursday, December 1, 2022

Delivering Stories of Progress

Advertisementspot_img

TAG

Pivotal bioVenture Partners

Zenas BioPharma Earmarks $118M to Fund Immunotherapy Project

Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies, today announced proceeds of $118...

Latest news